Laura Conti

27PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 28, 2026
Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer.

|Apr 14, 2026
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody.

Ahmad Salameh, Elisabetta Bolli, Manuela Iezzi

|Mar 05, 2026
Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment.

Antonino Di Lorenzo, Chiara Romiti, Alessandro Amaolo

|Dec 11, 2025
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer.

Lidia Tarone, Antonella Iacoviello, Antonino Di Lorenzo

|Oct 16, 2025
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets".

Laura Conti, Valentina Audrito

|Nov 09, 2024
Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern.

Chiara Cossu, Valentina Franceschi, Antonino Di Lorenzo

Pageof 5

Frequent Collaborators

18 joint publications

Federica Cavallo

10 joint publications

Antonino Di Lorenzo

8 joint publications

Federica Riccardo

5 joint publications

Elisabetta Bolli